SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹31 Cr | ₹0.40 Cr | ₹0.41 Cr | ₹0.50 Cr | ₹0.73 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹31 Cr |
Mar2022 | ₹0.40 Cr |
Mar2021 | ₹0.41 Cr |
Mar2020 | ₹0.50 Cr |
Mar2019 | ₹0.73 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹31 Cr | 7,629.35 | |
Mar2022 | ₹0.40 Cr | -1.23 | |
Mar2021 | ₹0.41 Cr | -17.78 | |
Mar2020 | ₹0.50 Cr | -32.01 | |
Mar2019 | ₹0.73 Cr | - |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹829.0 Cr | 12% | 7% | 115.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 12% |
7% |
115.2% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses